| 1 |
Mepenzolate bromide effect on lung: time course
|
Mus musculus
|
Mus musculus |
| Cell |
Lung |
| Perturbation |
Mepenzolate |
| Disease |
7 hr |
|
| 2 |
Mepenzolate bromide effect on lung: time course
|
Mus musculus
|
Mus musculus |
| Cell |
Lung |
| Perturbation |
Mepenzolate |
| Disease |
25 hr |
|
| 3 |
Acetaminophen effect on thioredoxin reductase ...
|
Mus musculus
|
Mus musculus |
| Cell |
Liver |
| Perturbation |
Acetaminophen |
|
| 4 |
Rheumatoid arthritic synovium response to ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Synovium |
| Perturbation |
rituximab |
| Disease |
Rheumatoid arthritis |
|
| 5 |
Acetaminophen effect on thioredoxin reductase ...
|
Mus musculus
|
Mus musculus |
| Cell |
Liver (TrxR1null) |
| Perturbation |
Acetaminophen |
|
| 6 |
Cediranib effect on metastatic alveolar soft ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Metastatic alveolar ... |
| Perturbation |
Cediranib |
| Disease |
Metastatic alveolar ... |
|
| 7 |
Ovarian cancer xenograft tumor response to ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Ovary |
| Perturbation |
Trastuzumab |
| Disease |
Ovarian cancer ... |
|
| 8 |
Ovarian cancer xenograft tumor response to ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Ovary |
| Perturbation |
Pertuzumab |
| Disease |
Ovarian cancer ... |
|
| 9 |
Glioblastoma cells response to Focal Adhesion ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
U87 glioblastoma cells |
| Perturbation |
Temozolomide |
| Disease |
Glioblastoma |
|
| 10 |
Pan-peroxisome proliferator-activated receptor ...
|
Mus musculus
|
Mus musculus |
| Cell |
Heart |
| Perturbation |
PPM201 (pan-PPAR agonist) |
| Disease |
6mg/kg |
|
| 11 |
Pan-peroxisome proliferator-activated receptor ...
|
Mus musculus
|
Mus musculus |
| Cell |
Heart |
| Perturbation |
PPM201 (pan-PPAR agonist) |
| Disease |
20mg/kg |
|
| 12 |
Pan-peroxisome proliferator-activated receptor ...
|
Mus musculus
|
Mus musculus |
| Cell |
Kidney |
| Perturbation |
PPM201 (pan-PPAR agonist) |
| Disease |
6mg/kg |
|
| 13 |
Pan-peroxisome proliferator-activated receptor ...
|
Mus musculus
|
Mus musculus |
| Cell |
Kidney |
| Perturbation |
PPM201 (pan-PPAR agonist) |
| Disease |
20mg/kg |
|
| 14 |
Pan-peroxisome proliferator-activated receptor ...
|
Mus musculus
|
Mus musculus |
| Cell |
Liver |
| Perturbation |
PPM201 (pan-PPAR agonist) |
| Disease |
6mg/kg |
|
| 15 |
Pan-peroxisome proliferator-activated receptor ...
|
Mus musculus
|
Mus musculus |
| Cell |
Liver |
| Perturbation |
PPM201 (pan-PPAR agonist) |
| Disease |
20mg/kg |
|
| 16 |
Pan-peroxisome proliferator-activated receptor ...
|
Mus musculus
|
Mus musculus |
| Cell |
Skeletal muscle |
| Perturbation |
PPM201 (pan-PPAR agonist) |
| Disease |
6mg/kg |
|
| 17 |
Pan-peroxisome proliferator-activated receptor ...
|
Mus musculus
|
Mus musculus |
| Cell |
Skeletal muscle |
| Perturbation |
PPM201 (pan-PPAR agonist) |
| Disease |
20mg/kg |
|
| 18 |
D-serine effect on the brain: dose response
|
Rattus norvegicus
|
Rattus norvegicus |
| Cell |
Forebrain |
| Perturbation |
Dserine |
| Disease |
5mg/kg |
|
| 19 |
D-serine effect on the brain: dose response
|
Rattus norvegicus
|
Rattus norvegicus |
| Cell |
Forebrain |
| Perturbation |
Dserine |
| Disease |
20mg/kg |
|
| 20 |
D-serine effect on the brain: dose response
|
Rattus norvegicus
|
Rattus norvegicus |
| Cell |
Forebrain |
| Perturbation |
Dserine |
| Disease |
50mg/kg |
|
| 21 |
D-serine effect on the brain: dose response
|
Rattus norvegicus
|
Rattus norvegicus |
| Cell |
Forebrain |
| Perturbation |
Dserine |
| Disease |
200mg/kg |
|
| 22 |
D-serine effect on the brain: dose response
|
Rattus norvegicus
|
Rattus norvegicus |
| Cell |
Forebrain |
| Perturbation |
Dserine |
| Disease |
500mg/kg |
|
